Article

Advances in glaucoma research continue

Paul Lichter, MD, for the Collaborative Initial Glaucoma Treatment Studyreported the results of an analysis of variables reflecting iOP controlassociated with visual field loss over 5 years. Four hundred twenty-sevenpatients who were followed for more than 6 years were analyzed. They hadbeen randomly assigned to medical therapy or a filtering procedure. Dr.Lichter reported that visual field loss was significantly associated witha larger maximum IOP, increased IOP variation, and a higher mean IOP. Dr.Lichter suggested that ophthalmologists focus on keep patient IOPs under18 mm Hg for as long as possible and avoid wide swings in IOP.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.